216 related articles for article (PubMed ID: 25624760)
1. Evaluation of 188Re-labeled PEGylated nanoliposome as a radionuclide therapeutic agent in an orthotopic glioma-bearing rat model.
Huang FY; Lee TW; Chang CH; Chen LC; Hsu WH; Chang CW; Lo JM
Int J Nanomedicine; 2015; 10():463-73. PubMed ID: 25624760
[TBL] [Abstract][Full Text] [Related]
2. Imaging, autoradiography, and biodistribution of (188)Re-labeled PEGylated nanoliposome in orthotopic glioma bearing rat model.
Huang FY; Lee TW; Kao CH; Chang CH; Zhang X; Lee WY; Chen WJ; Wang SC; Lo JM
Cancer Biother Radiopharm; 2011 Dec; 26(6):717-25. PubMed ID: 22145660
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model.
Lin LT; Chang CH; Yu HL; Liu RS; Wang HE; Chiu SJ; Chen FD; Lee TW; Lee YJ
J Nucl Med; 2014 Nov; 55(11):1864-70. PubMed ID: 25349220
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, dosimetry and comparative efficacy of 188Re-liposome and 5-FU in a CT26-luc lung-metastatic mice model.
Chen LC; Wu YH; Liu IH; Ho CL; Lee WC; Chang CH; Lan KL; Ting G; Lee TW; Shien JH
Nucl Med Biol; 2012 Jan; 39(1):35-43. PubMed ID: 21958858
[TBL] [Abstract][Full Text] [Related]
5. Involvement of let-7 microRNA for the therapeutic effects of Rhenium-188-embedded liposomal nanoparticles on orthotopic human head and neck cancer model.
Lin LT; Chang CY; Chang CH; Wang HE; Chiou SH; Liu RS; Lee TW; Lee YJ
Oncotarget; 2016 Oct; 7(40):65782-65796. PubMed ID: 27588466
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and pharmacokinetics of 188Re-liposomes and their comparative therapeutic efficacy with 5-fluorouracil in C26 colonic peritoneal carcinomatosis mice.
Tsai CC; Chang CH; Chen LC; Chang YJ; Lan KL; Wu YH; Hsu CW; Liu IH; Ho CL; Lee WC; Ni HC; Chang TJ; Ting G; Lee TW
Int J Nanomedicine; 2011; 6():2607-19. PubMed ID: 22114492
[TBL] [Abstract][Full Text] [Related]
7. MicroSPECT/CT imaging and pharmacokinetics of 188Re-(DXR)-liposome in human colorectal adenocarcinoma-bearing mice.
Chen MH; Chang CH; Chang YJ; Chen LC; Yu CY; Wu YH; Lee WC; Yeh CH; Lin FH; Lee TW; Yang CS; Ting G
Anticancer Res; 2010 Jan; 30(1):65-72. PubMed ID: 20150618
[TBL] [Abstract][Full Text] [Related]
8. Comparative therapeutic efficacy of rhenium-188 radiolabeled-liposome and 5-fluorouracil in LS-174T human colon carcinoma solid tumor xenografts.
Hsu CW; Chang YJ; Chang CH; Chen LC; Lan KL; Ting G; Lee TW
Cancer Biother Radiopharm; 2012 Oct; 27(8):481-9. PubMed ID: 23067100
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model.
Chang YJ; Chang CH; Yu CY; Chang TJ; Chen LC; Chen MH; Lee TW; Ting G
Nucl Med Biol; 2010 Jan; 37(1):95-104. PubMed ID: 20122674
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Differentially Expressed microRNAs in the PEGylated Liposome Encapsulated
Lin BZ; Wan SY; Lin MY; Chang CH; Chen TW; Yang MH; Lee YJ
Molecules; 2020 Aug; 25(16):. PubMed ID: 32784458
[TBL] [Abstract][Full Text] [Related]
11. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
Bao A; Goins B; Klipper R; Negrete G; Phillips WT
J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
Liu CM; Lee WC; Yu CY; Lan KL; Chang CH; Ting G; Lee TW
Oncol Rep; 2012 Mar; 27(3):678-84. PubMed ID: 22109644
[TBL] [Abstract][Full Text] [Related]
13. Comparative dosimetric evaluation of nanotargeted (188)Re-(DXR)-liposome for internal radiotherapy.
Chang CH; Stabin MG; Chang YJ; Chen LC; Chen MH; Chang TJ; Lee TW; Ting G
Cancer Biother Radiopharm; 2008 Dec; 23(6):749-58. PubMed ID: 19111045
[TBL] [Abstract][Full Text] [Related]
14. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
Emfietzoglou D; Kostarelos K; Sgouros G
J Nucl Med; 2001 Mar; 42(3):499-504. PubMed ID: 11337529
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of a 188Re-labeled alpha-melanocyte-stimulating hormone peptide analog in murine and human melanoma-bearing mouse models.
Miao Y; Owen NK; Fisher DR; Hoffman TJ; Quinn TP
J Nucl Med; 2005 Jan; 46(1):121-9. PubMed ID: 15632042
[TBL] [Abstract][Full Text] [Related]
16. External beam radiotherapy synergizes ¹⁸⁸Re-liposome against human esophageal cancer xenograft and modulates ¹⁸⁸Re-liposome pharmacokinetics.
Chang CH; Liu SY; Chi CW; Yu HL; Chang TJ; Tsai TH; Lee TW; Chen YJ
Int J Nanomedicine; 2015; 10():3641-9. PubMed ID: 26056445
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas.
Torres LA; Coca MA; Batista JF; Casaco A; Lopez G; García I; Perera A; Peña Y; Hernández A; Sanchez Y; Romero S; Leyva R; Prats A; Fernandez R
Nucl Med Commun; 2008 Jan; 29(1):66-75. PubMed ID: 18049099
[TBL] [Abstract][Full Text] [Related]
18. The PEGylated liposomal doxorubicin improves the delivery and therapeutic efficiency of 188Re-Liposome by modulating phagocytosis in C26 murine colon carcinoma tumor model.
Hsu WH; Liu SY; Chang YJ; Chang CH; Ting G; Lee TW
Nucl Med Biol; 2014 Oct; 41(9):765-71. PubMed ID: 25027866
[TBL] [Abstract][Full Text] [Related]
19. Imaging, biodistribution and efficacy evaluation of
Chen LC; Chang YJ; Chen SJ; Lee WC; Chang CH; Lee TW; Shien JH
Int J Radiat Biol; 2017 May; 93(5):477-486. PubMed ID: 28045339
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging and therapeutic efficacy of 188Re-(DXR)-liposome-BBN in AR42J pancreatic tumor-bearing mice.
Chang YJ; Yu CY; Hsu CW; Lee WC; Chen SJ; Chang CH; Lee TW
Oncol Rep; 2012 Nov; 28(5):1736-42. PubMed ID: 22922965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]